Trabectedin for recurrent WHO grade 2 or 3 meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG)Matthias Preusser, Wolfgang Wick, Alice Bonneville-Levard et al.|Neuro-Oncology|2021Cited by 81
Stereotactic radiosurgery versus whole-brain radiotherapy in patients with 4–10 brain metastases: A nonrandomized controlled trialRaphael Bodensohn, Maximilian Niyazi, Anna-Lena Kaempfel et al.|Radiotherapy and Oncology|2023Cited by 46
MRI-based contrast clearance analysis shows high differentiation accuracy between radiation-induced reactions and progressive disease after cranial radiotherapyRaphael Bodensohn, Maximilian Niyazi, Robert Forbrig et al.|ESMO Open|2022Cited by 25
P05.01 Prospective validation trial of magnetic resonance imaging based Contrast Clearance Analysis (CCA) to differentiate between pseudoprogression/radiation necrosis and progressive disease following cranial radiotherapyRaphael Bodensohn, Maximilian Niyazi, Robert Forbrig et al.|Neuro-Oncology|2021Cited by 1